STAT+: FDA approves Ultragenyx gene therapy

Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Today, we talk more about Merck and Moderna’s potentially field-changing cancer vaccine, see a couple FDA approvals, and learn more about the new FDA commissioner nominee. Plus, brain organoids have stayed alive — and continue to mature — in a Harvard lab for five years. I wonder, actually, about the poor little brain organoids in Megan’s story. Just pulsing in their Petri dishes, contemplating moral relativity or migraines. It’s all very Robin Cook. STAT+ Exclusive Story Already have an account? Log in This article is exclusive to STAT+ subscribers Unlock this article — plus in-depth analysis, newsletters, premium events, and news alerts. Already have an account? Log in View All Plans To read the rest of this story subscribe to STAT+. Subscribe